PURPOSE: The deleted-in-polyposis1-like1 (DP1L1) gene displays pro-apoptotic activity and was proposed to be a tumor suppressor. It locates on chromosome 19p13.3, which harbors the locus for Peutz-Jeghers-Syndrome and is deleted in various tumors. We analyzed the association of DP1L1 polymorphisms with colon cancer, and cancer-associated Ulcerative colitis and Crohn's disease. EXPERIMENTAL DESIGN: Fifty-eight patients with colon cancer, 18 with Ulcerative colitis, 18 with Crohn's disease, and 70 control individuals were genotyped for SNPs at positions 992 and 996 of DP1L1 cDNA. RESULTS: Homozygous carriers of 992A alleles comprised 16% of the control group but were significantly increased in colon cancer with a frequency of 36% (P = 0.013 cancer vs control). Homozygous 991-A was also elevated in Ulcerative colitis (N = 18) with a frequency of 33%. In contrast, 18 patients with Crohn's disease showed no difference in frequency of 992AA (22%) compared to control. The A-allele of the adjacent C996A polymorphism has a low frequency (3.5%) in the control population, but significantly increased frequency of 13% in colon cancer (P = 0.0149 for allele frequency, Fisher's exact). 996-A allele frequency is also increased in inflammatory bowel disease (IBD): 22% of Ulcerative colitis- and 50% of Crohn's disease-patients were heterozygous carriers of 996-A (P = 0.052 for CU and P < 0.0001 for MC vs controls). CONCLUSIONS: DP1L1 polymorphisms are associated with colon cancer and IBD. This indicates that DP1L1 plays a functional role in these conditions. Thus DP1L1 may be a diagnostic and therapeutic target for colon cancer and IBD.
PURPOSE: The deleted-in-polyposis1-like1 (DP1L1) gene displays pro-apoptotic activity and was proposed to be a tumor suppressor. It locates on chromosome 19p13.3, which harbors the locus for Peutz-Jeghers-Syndrome and is deleted in various tumors. We analyzed the association of DP1L1 polymorphisms with colon cancer, and cancer-associated Ulcerative colitis and Crohn's disease. EXPERIMENTAL DESIGN: Fifty-eight patients with colon cancer, 18 with Ulcerative colitis, 18 with Crohn's disease, and 70 control individuals were genotyped for SNPs at positions 992 and 996 of DP1L1 cDNA. RESULTS: Homozygous carriers of 992A alleles comprised 16% of the control group but were significantly increased in colon cancer with a frequency of 36% (P = 0.013 cancer vs control). Homozygous 991-A was also elevated in Ulcerative colitis (N = 18) with a frequency of 33%. In contrast, 18 patients with Crohn's disease showed no difference in frequency of 992AA (22%) compared to control. The A-allele of the adjacent C996A polymorphism has a low frequency (3.5%) in the control population, but significantly increased frequency of 13% in colon cancer (P = 0.0149 for allele frequency, Fisher's exact). 996-A allele frequency is also increased in inflammatory bowel disease (IBD): 22% of Ulcerative colitis- and 50% of Crohn's disease-patients were heterozygous carriers of 996-A (P = 0.052 for CU and P < 0.0001 for MC vs controls). CONCLUSIONS:DP1L1 polymorphisms are associated with colon cancer and IBD. This indicates that DP1L1 plays a functional role in these conditions. Thus DP1L1 may be a diagnostic and therapeutic target for colon cancer and IBD.
Authors: A H Wyllie; C O Bellamy; V J Bubb; A R Clarke; S Corbet; L Curtis; D J Harrison; M L Hooper; N Toft; S Webb; C C Bird Journal: Br J Cancer Date: 1999-07 Impact factor: 7.640
Authors: M De Rosa; M I Scarano; L Panariello; N Carlomagno; G B Rossi; A Tempesta; P Borgheresi; A Renda; P Izzo Journal: Eur J Hum Genet Date: 1999-09 Impact factor: 4.246
Authors: H Mehenni; C Gehrig; J Nezu; A Oku; M Shimane; C Rossier; N Guex; J L Blouin; H S Scott; S E Antonarakis Journal: Am J Hum Genet Date: 1998-12 Impact factor: 11.025
Authors: Kerstin Koenig-Hoffmann; Angelika L Bonin-Debs; Irene Boche; Beate Gawin; Andrea Gnirke; Christoph Hergersberg; Frank Madeo; Michael Kazinski; Matthias Klein; Christian Korherr; Dieter Link; Sascha Röhrig; Rolf Schäfer; Ulrich Brinkmann Journal: Int J Cancer Date: 2005-01-20 Impact factor: 7.396
Authors: S B Gruber; M M Entius; G M Petersen; S J Laken; P A Longo; R Boyer; A M Levin; U J Mujumdar; J M Trent; K W Kinzler; B Vogelstein; S R Hamilton; M H Polymeropoulos; G J Offerhaus; F M Giardiello Journal: Cancer Res Date: 1998-12-01 Impact factor: 12.701
Authors: Hong Hao; Shobi Veleri; Bo Sun; Douglas S Kim; Patrick W Keeley; Jung-Woong Kim; Hyun-Jin Yang; Sharda P Yadav; Souparnika H Manjunath; Raman Sood; Paul Liu; Benjamin E Reese; Anand Swaroop Journal: Hum Mol Genet Date: 2014-04-01 Impact factor: 6.150